Competing in the A.M, Partnering in the P.M.
Executive SummaryNo one turns to the device industry for a lesson on alliances. But Hewlett-Packard's Medical Products Group is setting a precedent well worth watching by drug companies. they have recognized the necessity of partnering with competitors.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.